Assess the Effect of Treating Periodontal Disease on Cardiovascular Function in Young Adults

April 19, 2013 updated by: Roberta A. Gottlieb, San Diego State University

Oral Flora, Periodontitis, and Vascular Dysfunction in Young Native Americans.

We propose to examine a population of Native Americans who have had little or no dental care, and to determine if periodontal disease is associated with early signs of vascular dysfunction or systemic inflammation. We then propose to treat the periodontitis and re-evaluate vascular function. We will determine if gingivitis or mild/moderate periodontitis is associated with detectable vascular dysfunction. Microbial metagenomics will be correlated with vascular function.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Valley Center, California, United States, 92082
        • Indian Health Council

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The study population comprises 200 Native Americans seeking health care at the Indian Health Council.

Description

Inclusion Criteria:

  • American Indian/Alaskan Natives seeking health care at the Indian Health Council, Inc.
  • Males and females aged 21-40 years.

Exclusion criteria:

  • Recent (within 6 months) periodontal treatment
  • History of high blood pressure or existing heart disease
  • Xerostomia
  • Currently receiving treatment for cancer
  • Currently taking anti-inflammatory medications (except H2 blockers, statins, or medications that can affect periodontal status
  • Immunosuppressed due to medication or HIV infection, or presence of active infection such as hepatitis or tuberculosis
  • Fewer than 20 teeth in functional dentition, excluding third molars, or other gross oral pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of bacterial populations in periodontal samples before and after standard periodontal treatment, stratified by severity of gum disease, using microbial metagenomics analysis.
Time Frame: Time of enrollment and at 6 week follow up visit
The study will assess if periodontal bacterial flora differ in patients with healthy gums, mild, or severe periodontal disease.
Time of enrollment and at 6 week follow up visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Roberta A Gottlieb, MD, San Diego State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2010

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

June 17, 2011

First Submitted That Met QC Criteria

June 17, 2011

First Posted (Estimate)

June 20, 2011

Study Record Updates

Last Update Posted (Estimate)

April 23, 2013

Last Update Submitted That Met QC Criteria

April 19, 2013

Last Verified

April 1, 2013

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atherosclerosis

3
Subscribe